First Phase of our Ibogaine Outcome Study Ends

We have ended the first phase of our ibogaine outcome study under the direction of John Harrison, Psy.D. candidate. We plan to analyze our current data from the 16 subjects who completed outcome visits in this study. We have plans to take a closer look at the current protocol, with an eye toward making improvements in the data collection process and study design. We will then reopen the study next year under a new protocol and enroll an additional pool of subjects.